Timeline | Returns | Volume |
---|---|---|
Daily | 2.90 | 36,28,496 |
Weekly | 20.71% | 10,99,75,400 |
Monthly | 22.32% | 14,83,81,322 |
Timeline | Daily | Weekly | Monthly |
---|---|---|---|
PPLPHARMA | 2.90 | 20.71% | 22.32% |
Index | - | - | - |
Peer Avg. | - | 2.18% | 10.12% |
Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
---|---|---|---|---|---|---|
PPLPHARMA | - | 1.21 | 18.71 | -2.77 | 1.95 | - |
Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
Peer Avg. | 38.60 | 4.35 | 13.48 | 12.96 | 16.49 | 0.78 |
Metrics | Sales Growth | Profit Growth | ROE | ROCE |
---|---|---|---|---|
FY '22-23 | 7.97% | -149.60% | -2.77% | 1.95% |
FY '21-22 | 4.59% | -47.48% | 6.80% | 8.13% |
FY '20-21 | - | - | 14.42% | 14.64% |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
FY '22-23 | 7,081.55 | 6,453.31 | 853.35 | -186.46 |
FY '21-22 | 4,827.02 | 4,153.55 | 923.17 | 359.50 |
FY '20-21 | 4,626.85 | 3,603.41 | 1,204.48 | 703.26 |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
PPLPHARMA | 7,081.55 | 6,453.31 | 853.35 | -186.46 |
CONCORDBIO | 853.17 | 504.59 | 383.89 | 240.08 |
LAURUSLABS | 4,821.31 | 3,467.49 | 1,372.24 | 791.26 |